Switch to:
Amgen Inc (NAS:AMGN)
Accounts Payable
$5,915 Mil (As of Sep. 2015)

Amgen Inc's quarterly accounts payable declined from Mar. 2015 ($5,836 Mil) to Jun. 2015 ($5,641 Mil) but then increased from Jun. 2015 ($5,641 Mil) to Sep. 2015 ($5,915 Mil).

Amgen Inc's annual accounts payable declined from Dec. 2012 ($5,696 Mil) to Dec. 2013 ($5,442 Mil) but then increased from Dec. 2013 ($5,442 Mil) to Dec. 2014 ($6,508 Mil).


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Amgen Inc Annual Data

Accts Payable 5,1444,1793,8863,8734,0825,6705,6965,4426,5086,417

Amgen Inc Quarterly Data

Accts Payable 4,8325,4425,6985,3666,0516,5085,8365,6415,9156,417
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership